These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11743024)

  • 1. RNAi is antagonized by A-->I hyper-editing.
    Scadden AD; Smith CW
    EMBO Rep; 2001 Dec; 2(12):1107-11. PubMed ID: 11743024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A-to-I editing of protein coding and noncoding RNAs.
    Mallela A; Nishikura K
    Crit Rev Biochem Mol Biol; 2012; 47(6):493-501. PubMed ID: 22988838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine-to-inosine RNA editing.
    Zinshteyn B; Nishikura K
    Wiley Interdiscip Rev Syst Biol Med; 2009; 1(2):202-209. PubMed ID: 20835992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A-to-I RNA editing - thinking beyond the single nucleotide.
    Ganem NS; Lamm AT
    RNA Biol; 2017 Dec; 14(12):1690-1694. PubMed ID: 28820319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of dsRNAs hyper-edited by ADARs occurs at preferred editing sites.
    Scadden AD; O'Connell MA
    Nucleic Acids Res; 2005; 33(18):5954-64. PubMed ID: 16254076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis.
    Erdmann EA; Mahapatra A; Mukherjee P; Yang B; Hundley HA
    Crit Rev Biochem Mol Biol; 2021 Feb; 56(1):54-87. PubMed ID: 33356612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editor meets silencer: crosstalk between RNA editing and RNA interference.
    Nishikura K
    Nat Rev Mol Cell Biol; 2006 Dec; 7(12):919-31. PubMed ID: 17139332
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Reich DP; Tyc KM; Bass BL
    Genes Dev; 2018 Feb; 32(3-4):271-282. PubMed ID: 29483152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific cleavage of hyper-edited dsRNAs.
    Scadden AD; Smith CW
    EMBO J; 2001 Aug; 20(15):4243-52. PubMed ID: 11483527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome diversification by adenosine to inosine RNA editing.
    Pullirsch D; Jantsch MF
    RNA Biol; 2010; 7(2):205-12. PubMed ID: 20200492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
    Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
    RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential selection of adenosines for modification by double-stranded RNA adenosine deaminase.
    Polson AG; Bass BL
    EMBO J; 1994 Dec; 13(23):5701-11. PubMed ID: 7527340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine to inosine editing by ADAR2 requires formation of a ternary complex on the GluR-B R/G site.
    Jaikaran DC; Collins CH; MacMillan AM
    J Biol Chem; 2002 Oct; 277(40):37624-9. PubMed ID: 12163487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage.
    Scadden AD
    Nat Struct Mol Biol; 2005 Jun; 12(6):489-96. PubMed ID: 15895094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA editing by ADAR1 leads to context-dependent transcriptome-wide changes in RNA secondary structure.
    Solomon O; Di Segni A; Cesarkas K; Porath HT; Marcu-Malina V; Mizrahi O; Stern-Ginossar N; Kol N; Farage-Barhom S; Glick-Saar E; Lerenthal Y; Levanon EY; Amariglio N; Unger R; Goldstein I; Eyal E; Rechavi G
    Nat Commun; 2017 Nov; 8(1):1440. PubMed ID: 29129909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAR editing in double-stranded UTRs and other noncoding RNA sequences.
    Hundley HA; Bass BL
    Trends Biochem Sci; 2010 Jul; 35(7):377-83. PubMed ID: 20382028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editing independent effects of ADARs on the miRNA/siRNA pathways.
    Heale BS; Keegan LP; McGurk L; Michlewski G; Brindle J; Stanton CM; Caceres JF; O'Connell MA
    EMBO J; 2009 Oct; 28(20):3145-56. PubMed ID: 19713932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
    Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
    Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A protein-protein interaction underlies the molecular basis for substrate recognition by an adenosine-to-inosine RNA-editing enzyme.
    Rajendren S; Manning AC; Al-Awadi H; Yamada K; Takagi Y; Hundley HA
    Nucleic Acids Res; 2018 Oct; 46(18):9647-9659. PubMed ID: 30202880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitutional A-to-I RNA editing.
    Wulff BE; Nishikura K
    Wiley Interdiscip Rev RNA; 2010; 1(1):90-101. PubMed ID: 21072321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.